Dr. McCarthy on Eligibility Criteria for Allogeneic BMT

Video

Philip L. McCarthy, MD, Director, Blood & Marrow Transplant Program, Department of Medicine, Roswell Park Cancer Institute, explains the factors that determine patient tolerability to allogeneic bone marrow transplant.

Philip L. McCarthy, MD, Director, Blood & Marrow Transplant Program, Department of Medicine, Roswell Park Cancer Institute, explains the eligibility criteria he uses to determine patient tolerability to allogeneic bone marrow transplant.

The upper age limit for patients eligible to undergo allogeneic bone marrow transplant has progressed from 50 years to 70 years since the 1980s. Some older patients remain eligible for allogeneic bone marrow transplant because of their overall health and activity, regardless of their age, McCarthy explains.

Patients with underlying kidney, heart or lung disease may not be able to handle the rigors of a transplant. McCarthy says that a 40-year-old with severe cardiac disease will not be an adequate allogeneic transplant candidate whereas a 70-year-old could be, based on comorbidities.

Related Videos
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD
James Knight, MD
Jason Efstathiou, MD, DPhil